Quantitative PCR is the diagnostic pillar for clinical virology testing, and 17 reference materials are necessary for accurate, comparable quantitation between clinical 18 laboratories. Accurate quantitation of HHV-6 is important for detection of viral 19 reactivation and inherited chromosomally integrated HHV-6 in immunocompromised 20 patients. Reference materials in clinical virology commonly consist of laboratory-21 adapted viral strains that may be affected by the culture process. We performed next-22
generation sequencing to make relative copy number measurements at single nucleotide 23 resolution of eight candidate HHV-6A and seven HHV-6B reference strains and DNA 24 materials from the HHV-6 Foundation and Advanced Biotechnologies. 11 of 17 (65%) 25 HHV6 candidate reference materials showed multiple copies of the origin of replication 26 upstream of the U41 gene by next-generation sequencing. These large tandem repeats 27 arose independently in culture-adapted HHV-6A and HHV-6B strains, measuring 1254 28 bp and 983 bp, respectively. Copy number measured between 4-10X copies relative to 29 the rest of the genome. We also report the first interspecies recombinant HHV-6 strain 30 with a HHV-6A GS backbone and >5.5kb region from HHV-6B Z29 from U41-U43 that 31 covered the origin tandem repeat. Specific HHV-6A reference strains demonstrated 32 duplication of regions at UL1/UL2, U87, and U89, as well as deletion in the U12-U24 33 region and U94/95 genes. HHV-6 strains derived from cord blood mononuclear cells 34 from different labs on different continents revealed no copy number differences 35 throughout the viral genome. These data indicate large origin tandem duplications are an 36 adaptation of both HHV-6A and HHV-6B in culture and show interspecies recombination 37 is possible within the Betaherpesvirinae.
Introduction 58
Human herpesvirus 6A and 6B (HHV-6) are ubiquitous human viruses with 59 human exposure levels >90% by the age of 2 years old as measured by serological assays 60 performed worldwide (1, 2) . Both HHV-6A and HHV-6B establish chronic infections in 61 the majority of infected individuals, leading to asymptomatic persistent viral shedding (3, 62 4). Exanthema subitum is the most common HHV-6 related infection seen after a primary 63 exposure in 6 month to 3-year old children. Less frequently the virus can result in 64 seizures, gastrointestinal and respiratory symptoms, thrombocytopenia, hepatitis, colitis, 65 and CNS infections. Additionally, both HHV-6A and HHV-6B have been shown to 66 integrate into host chromosomes in the telomere regions and be passed from parents to 67 their children as inherited chromosomally integrated HHV-6 (iciHHV-6). The potential to 68 measure HHV-6 from genomic DNA from these patients, as well as possible reactivation 69 from the integrated HHV-6 make the diagnosis of HHV-6 infection from serum or 70 plasma viral load testing challenging. 71
Accurate and sensitive real-time PCR assays that detect and quantify HHV-6 are 72 critical to diagnosis and monitoring of the variety of manifestations of HHV-6 associated 73 disease. Recently several quantitative cut-offs have been proposed that are associated 74 with end-organ disease or iciHHV-6 status (5-7). There have been only a few limited 75 studies comparing PCR methods between clinical labs (8-10). In addition, newer studies 76 often utilize commercial reference laboratories or commercial reagents that in general do 77 not make their primer/probe locations known. Of published studies where the PCR 78 locations are described, many areas of the genome have been used, with no consistent 79 location chosen. A review of the PCR methods used in 46 recent published papers (years 80 2014-2017) revealed the use of 17 different primer sets at multiple locations throughout 81 the genome (at U6, 12, 13, 22, 27, 31, 32, 38, 41, 57, 65, 66, 67, 69, 90, 95, 100), with  82 only the U31 and U65-66 primers used more than twice. Not surprisingly, this lack of 83 consistency has contributed to a significant lack of consistency in test results as measured 84 in cross-lab proficiency testing where quantitative differences as high as 4 logs have been 85 seen (10, 11). These studies hint that between-lab results may be improved if diagnostic 86 testing was done with a more limited number of high-performing primer sets. Finally, 87 effective primer designs have been significantly limited by the lack of available DNA 88
sequences. 89
Previous studies have identified the critical role that standardized materials play 90 in the ability to establish clinical viral load cut-offs, establish assay sensitivity, and 91 compare results between laboratories (10, 12-16). Efforts are currently underway at the 92 National Institute for Biological Standards and Controls (NIBSC) in the United Kingdom 93 to prepare WHO international standard material for both HHV-6A and 6B. However, 94 since this effort utilizes cultured HHV-6 reference strains, it is unknown how well the 95 materials utilized will reflect sequences in clinical isolates. Given the wide range of 96 primer set locations used in labs, it is critical that the entire genome of any reference 97 materials be studied 98 HHV-6A and -6B genomes have approximately 90% nucleotide identity to each 99 other and about 50% similarity with the closest-related human betaherpesvirus, HHV-7. 100
The genome is approximately 160-170 kb and contains many of the gene and regulatory 101 elements present in the genome of other betaherpesviruses. Several prototypic strains of 102 HHV-6 have been identified and utilized including GS, U1102, SIE, LHV, Z29, and HST. Until very recently, there were fewer than 200 HHV-6 sequences in Genbank, 104 including only 3 complete genomes. Recently, two large scale efforts have sequenced 105 more than 150 near-full length HHV-6B genomes from four continents (17, 18) . 106
In an effort to determine whether the available cultured "reference" strains have 107 undergone significant changes during culture similar to that seen with the recently 108 produced WHO BK and JC strains, we obtained 15 strains from the HHV-6 Foundation 109 repository and used shotgun sequencing to obtain full-length genomes and estimate of 110 copy number (19, 20) . We found 9 of the 15 strains had high-copy tandem repeat 111 amplifications in the origin of replication, including the first described origin 112 amplification in an HHV-6A strain. We also describe the first HHV-6A/HHV-6B 113 interspecies recombinant. Other HHV-6 reference materials had multiple loci with copy 114 number variation of up to 20X. These duplications, deletions, and rearrangements may 115 impact the utility of these strains for the production of standard materials for PCR testing. 116
Changes in the genome of these strains in culture may have impact on the results of 117 current and future studies utilizing these materials. 118 119
Materials and Methods 120
HHV-6 reference strains and DNA materials 121 HHV-6 culture isolates were obtained from the HHV-6 Foundation. The original 122 HHV-6 isolate GS belongs to HHV-6A and was first isolated at the National Cancer 123 Institute, NIH in 1986 from an AIDS patient. The HHV-6A GS strain was grown in 124 HSB2, which is a human T-cell leukemic line derived from the peripheral blood of a 125 child. The GS early passage isolate obtained from the HHV-6 Foundation is a low-126 passaged HHV-6A GS isolate that was only passaged 4 times in cord blood mononuclear 127 cells (CBMC). The GS early passage isolate was sequenced in 2013 after a brief 128 expansion in CBMC and sequencing reads were obtained from L. Flamand (21) . The 129 HHV-6A DA strain was isolated at the NCI from a patient with chronic fatigue syndrome 130 and was grown in the HSB2 cell line. The HHV-6A CO strains CO1, CO2, CO3, CO4, 131 CO7 were isolated from patients with collagen vascular diseases including systemic 132 lupus erythematosus, atypical polyclonal lymphoproliferation, rheumatoid arthritis, and 133 unclassified collagen vascular disease (22) . The HHV-6A SIE strain was isolated from 134 an HIV-positive leukemia patient from the Ivory Coast and grown in PHA-stimulated 135
CBMCs. The HHV-6B strains HST, KYO, ENO, and NAK were isolated from Japanese 136 patients with exanthema subitum in 1988 (23). The HHV-6B MAR strain was originally 137 obtained from an HIV-negative child born to an HIV-positive mother, and has been 138 cultured in CBMCs (24). HHV-6B Z29 strain was originally isolated from an AIDS 139 patients from Zaire and obtained from the HHV-6 Foundation stock deposited at the NIH 140 AIDS repository and grown in the SupT1 cell line. Secondary HHV-6 standards 141 comprising quantitated viral DNA from HHV-6A GS strain (08-945-250) and HHV-6B 142 Z29 strain (08-923-00) were purchased from Advanced Biotechnologies Incorporated. 143
Strains sequenced in this study are available in Table 1 . and/or 1x192bp runs on an Illumina MiSeq. Sequences were quality-and adapter-151 trimmed, de novo assembled, and contigs were aligned to reference HHV-6A 152 (NC_001664) and HHV-6B (NC_000898) genomes and visualized using Geneious v9. 1. 153 Read mapping for copy number analysis was performed using the Geneious read mapper 154 with 10% allowed gaps per read, word length of 18, 20% maximum mismatches per read, 155 and with structural variant, insertion, and gap finding allowed. 156 157 qPCR confirmation 158
Quantitative PCR to estimate HHV-6 and beta-globin copy number in Table 1 Quantitive PCR to estimate relative copy number between the origin of 172 replication and HHV-6 U32 locus was performed in 20uL reactions using the 173 SsoAdvanced Universal SYBR Green SuperMix. Ten-fold dilutions of DNA template 174 from HHV-6 strains were tested using quantU32 F-R and species-specific origin primers 175 (Table S1 ) using cycling conditions of 95C 30s and 40 cycles of 95C 5s and 60C 30s. 176
For the U95 deletion in the CO strains, CO4 142970F-143228R primers (Table S1) were 177 used in the same cycling conditions with SsoAdvanced Universal SYBR Green 178 SuperMix, while the U32-targeting qPCR was performed with the U32 primers and a 179
Taqman probe (Table S1) In order to obtain single nucleotide resolution and copy number measurement for 200 HHV-6 type strain reference materials, we sequenced a HHV-6A GS strain obtained from 201 the HHV-6 Foundation and a HHV-6B Z29 strain obtained from the NIH AIDS 202 repository. Libraries from the HHV-6 Z29 and GS strain were each prepared twice and 203 sequenced to an average depth of 76X and 453X, respectively. The HHV-6B Z29 strain 204 contained a homogeneous 983 bp long tandem repeat ( Figure 1A ). Copy number 205 estimates based on relative coverage at the edge of the repeats across multiple library 206 preparations indicated an average of 11-13 copies of the repeat present. Mapping of the 207 edges of the Z29 origin tandem repeat gave different repeat breakpoints than previously 208 described (28). All Z29 strains sequenced in this study had an additional 123 nucleotides 209 at the 5' end of the repeat and extra 4 nucleotides at the 3' end of the repeat than the 210 previously described repeat to make the 983 bp tandem repeat (28). 211 HHV-6A GS strain contained a heterogeneous tandem repeat that covered 1260 212 bp of the HHV-6A reference genome ( Figure 1B To demonstrate that the copy number heterogeneity we found in the type strains 218 of HHV-6 are also present in commercially available quantitative clinical reference 219 materials, we also performed shotgun DNA sequencing on an HHV-6A GS strain and 220 HHV-6B Z29 strain from Advanced Biotechnology Inc (ABI). These strains had similar 221 tandem repeats in size at the origin of replication present in the GS strain obtained from 222 the HHV-6 Foundation and Z29 strains obtained from NIH AIDS repository ( Figure 1C ). 223
However, the Z29 origin tandem repeat in the commercial reference material was present 224 at approximately twice the copy number observed in Z29 from the NIH AIDS repository. 225
Intriguingly, the HHV-6A GS strain quantitative secondary standard material also 226 contained a 4-fold increase in coverage covering the U90, U91, and the N-terminal two-227 thirds of the U86 gene. The U91 end of the repeat contained a complex rearrangement 228 with the U100-DR intergenic region 266 nucleotides 5' of the beginning of the annotated 229 DR repeat region. The HHV-6B Z29 secondary standard contained two large 230 rearrangements --one between U73 and R3 repeat region constituting 50% of DNA 231 present and another between U86 and U95 representing 25% of DNA present. Thus, 232 copy number of HHV-6B between U86 to R3 was 4-fold lower and between U73-U86 233 and R3-U95 was 2-fold lower than the rest of the genome. Quantitative PCR analysis of 234 origin and U32 loci confirmed deep sequencing data, demonstrating a 3-4 cycle earlier Ct 235 for origin tandem repeat containing strains compared to strains lacking origin tandem 236 repeats. Of note, an early passage GS strain had 3-fold fewer copies of the origin than 237 the later passage GS-HSB2 strain, consistent with what has been described previously in 238 Z29 (28). 239
Previous analysis of 125 HHV-6B genomes obtained from clinical specimens 240 revealed no tandem repeats across the origin of replication. To confirm the origin tandem 241 repeat present in the HHV-6B Z29 strain, we performed PCR amplification and fragment 242 analysis by gel electrophoresis across the sequence tandem repeat with two separate 243 primer sets. As a control, we performed PCR across the origin of replication in a HHV-244 6B PCR-positive patient specimen. The patient specimen demonstrated a single copy of 245 the locus present, while the Z29 strain contained an amplification ladder consistent with a 246 population of virus with different numbers of multiple tandem repeats present at the locus 247 ( Figure 2A) . We also performed amplification-free nanopore sequencing on DNA 248 extracted from the HHV-6B Z29 strain in culture. Across 6,369 nanopore reads, we 249 recovered two reads that contained more than one copy of the origin tandem repeat 250 ( Figure 2B ). One read contained three tandem repeats of the origin repeat, while the 251 other contained two repeats. Neither read spanned the entire tandem repeat. 252
253
Interspecies recombination between HHV-6A and HHV-6B in strain DA 254
Whole genome sequencing of the HHV6 DA strain revealed a hybrid genome 255 indicative of interspecies recombination between HHV-6A and HHV-6B strains. The 256 DA strain genome overall showed closest sequence identity to HHV-6A than HHV-6B 257 strains but included an oriLyt repeat that measured the exact length of the Z29 repeat at 258 983 bp ( Figure 3A) . The DA strain U38 gene matched with perfect identity to the HHV-259 6A GS strain by BLASTN analysis. Of note, the DA strain origin-binding protein U73 260 gene matched closer to the HHV-6A U73 than HHV-6B U73 (99.5% versus 97.1% 261 pairwise nucleotide identity to HHV-6A and HHV-6B reference strain genomes, 262 respectively). 263
Analysis of the DA strain sequence yielded consensus recombination breakpoints 264 at 67,314 bp and 72,667 bp of the NC_001664 that were detected by six of seven 265 recombination analysis programs (RDP4, GENECONV, Bootscan, MaxChi, Chimaera, 266 and 3Seq) ( Figure 3B ). Reads mapped with near identity along a 5.5kb region of the 267 HHV-6B Z29 reference genome between the 5' end of U41 and 3' end of U43 (68535-268 73824 bp of NC_000898) ( Figure 3C ). Only a 61bp fragment with oriLyt repeat had 6 269 variant sites to HHV-6B sequences and matched identically to the HHV-6A sequences in 270 this ( Figure 3D ). These sequences were just 3' from the end of the minimal origin of 271 DNA replication annotated in the HHV-6A reference genome. The length of the HHV-272 6B sequence present in the DA strain is likely considerably longer than the 5.5kb shown 273 on the reference genome, due to the presence of the oriLyt repeat. Strain DA also 274 contained a 33bp deletion in the 3' end of U79 gene that is not represented in either 275 HHV-6A or HHV-6B reference sequences. 276
277

Large deletions in U12-U24 genes and U94-U95 genes from two laboratory-adapted 278
HHV-6A strains from collagen vascular disease 279
Five HHV-6A strains isolates from patients with collagen vascular disease also 280 grew to high copy number in HSB2 cells. Isolates CO1, CO2, and CO3 were cultured in 281 primary peripheral blood lymphocytes for 17-21 days and then HSB2 cells for 4-5 days, 282 while isolates CO4 and CO7 were cultured for 2 days in primary cells and 42-46 days in 283 HSB2 cells (22) . The five CO isolates were highly similar with an average pairwise 284 nucleotide identity of >99.9%, while all five isolates most closely aligned to HHV-6A 285 isolate GS (KJ123690.1, 99.2% pairwise nucleotide identity). Both isolates CO4 and 286 CO7 had 60% decreased coverage in a 13.5kb region from U12-U24 relative to the CO1-287 CO3 isolates ( Figure 4A ). Most notably, both isolates CO4 and CO7 also had 95% lower 288 coverage over a 4.9kb region covering genes U94 and U95 relative to CO1-CO3 isolates. 289
Equivalent relative copy number estimates for both the U95 locus and the origin of 290 replication were recovered by qPCR ( Figure 4B /C). Isolates CO4 and CO7 both had 291 equivalent mixed variant allele frequencies at 25 loci based on read mapping to the UL 292 region of the HHV-6A reference genome (NC_001664) ( Table S2) 
. No other variants 293
were isolated between the HHV-6 CO4 and CO7 strains, suggesting these strains are 294 identical. 295
296
HHV-6 strains isolated from PHA-stimulated cord blood mononuclear cells do not 297 contain large tandem duplications or deletions 298
To find the best secondary standard for HHV-6 clinical testing and to better 299 understand the origin of the origin tandem repeat, we sequenced four HHV-6B and one 300 HHV-6A strain that were isolated from PHA-stimulated cord blood mononuclear cells. 301
Four HHV-6B strains (HST, ENO, KYO, NAK) were isolated from Japanese exanthem 302 subitum patients, one HHV-6B strain (MAR) was isolated from an asymptomatic French 303 child, and one HHV-6A strain (SIE) was isolated from an Ivory Coast patient with adult 304 T-cell leukemia (23, 24, 29). Interestingly, all six strains contained minimal levels of 305 copy number heterogeneity with an average coefficient of variation of coverage in the unique long region of 21.0%, compared with 119% averaged over HHV-6A GS and 307 HHV-6B Z29 type strains ( Figure 5A ). The lack of origin amplification in these CBMC-308 passaged strains was also confirmed by qPCR ( Figure 5B ). Without the tandem repeat in 309 the origin, the only source of copy number differences in the cord blood mononuclear 310 passaged strains was direct repeat coverage at two-thirds of that in the unique long 311 region, consistent with active replication and sequencing of mostly HHV-6 concatemers 312 ( Figure 5A ) (30). Of note, the decreased coverage in the direct repeat region relative to 313 the unique long region was present in all strains sequenced in this study. 314 315 Discussion 316
We show the presence of copy number heterogeneity at multiple genomic loci 317 across HHV-6A and HHV-6B culture isolates that are used as reference material for 318 clinical assay development and normalization as well as basic science virology work. 319
The most prominent copy number difference was a large tandem repeat in the origin of 320 replication that was present in both HHV-6A and HHV-6B strains. The presence of 321 large copy number differences in HHV-6A and HHV-6B strains was associated with 322 passaged in immortalized cell lines, as strains passaged in primary cell lines and cord 323 blood mononuclear cells did not carry genomic duplications and deletions and early 324 passage virus contained fewer tandem repeats than late passage virus. 325
Recent analysis of 130 HHV-6B genomes and 10 iciHHV-6A sequences spanning 326 the U41 origin region revealed no large tandem repeats in the origin of replication among 327 clinical isolates (18). Previous work had illustrated a large heterogeneous tandem repeat 328 present at the oriLyt in HHV-6B Z29 strains that was associated with higher passage 329 number (28). Our data illustrate that this is a general feature of HHV-6 and that a 330 heterogeneous larger tandem repeat is also present in multiple laboratory adapted HHV-331 6A strains at the oriLyt. We show that increased culture passage in immortalized cell 332 lines is associated with reduced copy number of two large genomic loci in HHV-6A CO 333 strains. Copy number variability at multiple genomic loci was also reflected in HHV-6A 334 reference material that is used to normalize quantitative values for clinical assay 335 development. Interestingly, no HHV-6 isolate from cord blood mononuclear cells 336 showed tandem repeats, despite growing to high titer. These isolates may provide the 337 best material for HHV-6 standards development. 338
We also show the first genomic evidence of interspecies recombination between 339 HHV-6A and HHV-6B strains along a >5.5 kb segment containing the oriLyt and U42 340 gene as well as portions of the U41 and U43 genes. Interspecies recombination is a 341 relatively common feature of the alphaherpesviruses HSV-1 and HSV-2 but has not been 342 described for any other human herpesviruses (31). Our results for DA strain 343 recombination are most consistent with a model in which co-cultivation of an HHV-6A 344 GS strain with a laboratory-adapted HHV-6B Z29 strain with oriLyt repeat that resulted 345 in recombination between the two strains. Interestingly the recombinant strain also 346 showed HHV-6A-like sequence in its HHV-6B oriLyt tandem repeat. Although this 347 sequence fell outside the minimal origin of replication, it is suggestive that the oriLyt 348 tandem repeat sequence may have evolved to more effectively interact with HHV-6A 349 replication proteins contained in the rest of genome. No specific HHV-6B-like sequences 350 were found in the DA strain U73 origin binding protein to indicate reciprocal U73 351 evolution to match the HHV-6B-like origin sequences. Recent analysis of 140 HHV-6 genomes from clinical and iciHHV-6 isolates revealed no evidence of interspecies 353 recombination but widespread intraspecies recombination (18). Whether interspecies 354 recombination has occurred in clinical strains of HHV-6 remains to be determined. 355
However the high sequence similarity between HHV-6A and HHV-6B and the frequency 356 of alphaherpesvirus recombination suggests that as more sequencing is performed, HHV-357 6A and HHV-6B recombinants may be found in nature. several copy number differences. A) Coverage maps from five HHV-6A strains isolated 414 from different patients with collagen vascular diseases are displayed (22) . These strains 415 all showed a similar heterogeneous tandem repeat that gave a mode length of 1254 bp. 416
Strains CO4 and CO7 which were passaged >40 times in immortalized HSB2 cell lines 417 also demonstrated 60% and 95% lower coverage in U12-U24 and U94-U95 regions, 418 respectively. Of note, these two strains also shared identical sequence and minor allele 419 distribution, consistent with being the same strain. B/C) qPCR analysis of ten-fold dilutions of DNA from the HHV-6A CO strains at the U32, U95, and origin loci confirms 421 relative copy number estimates from deep sequencing data. 
